CD Genomics Redefines RNA Sequencing with Revolutionary Ultra Low RNA Sequencing Technology

CD Genomics, a trailblazing leader in genomics services, is thrilled to introduce its latest breakthrough: Ultra Low RNA Sequencing. This cutting-edge technology represents a significant step forward in the field of RNA sequencing, offering researchers improved precision, sensitivity, and cost-efficiency.


In the ever-evolving landscape of genomics research, conventional RNA sequencing methods have often posed formidable challenges, necessitating substantial input material and resources. CD Genomics' Ultra Low RNA Sequencing, however, emerges as a game-changing solution poised to redefine the transcriptomics research landscape.


Key Features of Ultra Low RNA Sequencing:

Unprecedented Sensitivity: Ultra Low RNA Sequencing delivers unmatched sensitivity, empowering researchers to detect even the most elusive RNA molecules. This revolutionary capability allows for the exploration of rare or low-abundance transcripts with newfound depth and precision.


Minimal Input Requirement: With Ultra Low RNA Sequencing, a mere 1 ng of RNA is all that's required to initiate analysis. This remarkable reduction in input material enables the study of precious or limited samples that were once off-limits.


Cost-Efficiency: By minimizing input requirements and employing advanced library preparation techniques, Ultra Low RNA Sequencing significantly reduces sequencing costs without compromising the integrity of the data. Researchers can now embark on comprehensive transcriptomic studies without budgetary constraints.


Enhanced Accuracy: Leveraging cutting-edge error correction algorithms, Ultra Low RNA Sequencing ensures the highest level of data accuracy in RNA sequencing. Researchers can confidently rely on the results obtained from this technology for their critical experiments and analyses.


Versatility: Ultra-low RNA Sequencing exhibits adaptability across a diverse range of applications, including single-cell RNA sequencing, low-quality RNA samples, and even formalin-fixed, paraffin-embedded (FFPE) samples. Its flexibility renders it an indispensable tool for a multitude of research needs.


Why CD Genomics for Ultra Low RNA Sequencing:

CD Genomics boasts an illustrious reputation for delivering world-class genomics services on a global scale. The CD Genomics team of experts is unwavering in their commitment to remain at the forefront of genomic technologies, offering tailored solutions that seamlessly align with unique research objectives.


When selecting CD Genomics for Ultra Low RNA Sequencing, researchers can anticipate:

Exceptional Data Quality: CD Genomics leverages state-of-the-art sequencing platforms and rigorous quality control protocols to ensure the generation of data that is both accurate and reliable.


Personalized Support: CD Genomics collaborates closely with researchers to design custom workflows that precisely match the intricacies of individual projects.


Timely Results: CD Genomics understands the urgency of timely results and, therefore, employs streamlined processes to guarantee prompt data delivery, enabling researchers to progress seamlessly.


CD Genomics is unwavering in its commitment to innovation, pushing the boundaries of genomics research. Through Ultra Low RNA Sequencing, CD Genomics empowers researchers to embark on an expedition into the RNA universe with unprecedented precision, sensitivity, and cost-effectiveness. Join CD Genomics in revolutionizing transcriptomics research and together, unlock the hidden secrets within the RNA realm.


About CD Genomics

CD Genomics stands as a premier provider of genomics services, specializing in sequencing and bioinformatics. With an unwavering dedication to quality, innovation, and customer satisfaction, CD Genomics serves researchers worldwide as they pursue groundbreaking discoveries.



Address: Shirley, NY 11967, USA